Proliferative index in astrocytic tumours

Area of Science:

• Neuro-oncology
• Pathology
• Immunohistochemistry

Background:

• Accurate grading of astrocytic tumors is crucial for patient management and prognosis.
• The World Health Organization (WHO) grading system relies on histological features of H&E stained sections.
• Distinguishing between low-grade (II) and anaplastic (III) astrocytomas can be challenging, especially with small biopsies.

Purpose of the Study:

• To evaluate the utility of the MIB-1 labeling index (MIB-1 LI) in differentiating astrocytic tumor grades.
• To determine if MIB-1 LI can aid in distinguishing between WHO grade II, III, and IV astrocytomas.
• To assess the correlation between MIB-1 LI and the histological grade of astrocytic tumors.

Main Methods:

• Studied 90 formalin-fixed paraffin-embedded astrocytic tumor specimens (30 each of grade II, III, and IV).
• Performed MIB-1 immunostaining using a standard indirect immunoperoxidase technique.
• Calculated the MIB-1 labeling index (MIB-1 LI) for each tumor and performed statistical analysis (Unpaired "t" test, One way ANOVA).

Main Results:

• Mean MIB-1 LI values were 1.75% for grade II, 8.74% for grade III, and 20.54% for grade IV astrocytomas.
• Statistically significant differences were observed between grade II and III (p < 0.001) and grade III and IV (p < 0.001).
• A significant positive correlation was found between increasing histological grade and mean MIB-1 LI (p < 0.001).

Conclusions:

• The MIB-1 labeling index is a statistically significant and useful tool for grading astrocytic tumors.
• MIB-1 LI assists in differentiating between various grades of astrocytic malignancy, including challenging cases.
• Routine use of MIB-1 LI can improve the accuracy of astrocytic tumor grading, guiding treatment decisions and patient outcomes.